✦ LIBER ✦

Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery

✍ Scribed by Eckle, T; Lang, P; Prix, L; Jahn, G; Klingebiel, T; Handgretinger, R; Selle, B; Niethammer, D; Hamprecht, K

Book ID: 110013392
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 126 KB
Volume: 30
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1703666

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immune reconstitution and cytomegaloviru

Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion

✍ Martin Schmidt-Hieber; S. Schwarck; A. Stroux; S. Ganepola; P. Reinke; E. Thiel; 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 282 KB

Evaluation of the Murex CMV DNA Hybrid C

Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant

✍ Hebart, H; Wuchter, P; Loeffler, J; Gscheidle, B; Hamprecht, K; Sinzger, C; Jahn 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

Lack of association between the kinetics

Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant

✍ Isabel Muñoz; Antonio Gutiérrez; Concepción Gimeno; Amparo Farga; Juan Alberola; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

The kinetics of the gB-specific and neutralizing antibody responses to human cytomegalovirus (HCMV) were analyzed in 26 allogeneic stem-cell transplant recipients who either did (n = 20) or did not (n = 6) develop asymptomatic HCMV active infection during the study period. Antibody response profiles

Case Report: Persistent cytomegalovirus

Case Report: Persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes

✍ Kumi Oshima; Yoshinobu Kanda; Shinichi Kako; Yuki Asano-Mori1; Takuro Watanabe; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract Addition of in vivo alemtuzumab to the conditioning regimen enabled 2‐ or 3‐locus‐mismatched hematopoietic stem cell transplantation with an acceptable incidence of graft‐versus‐host‐disease. However, the procedure was associated with a high incidence of cytomegalovirus (CMV) reactivati